Sight Sciences
Develops interventional devices for glaucoma surgery and dry eye treatment.
$8.55
After-hours close+0.02 (+0.23%)
At close$8.53(+1.43%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 41.40%22.52M sharesInsiders 33.21%18.07M sharesOther 25.39%13.82M shares
Shares outstanding 54.41M · Float 35.12M · 64.5% free float
Institutions13F, as of Mar 31, 2026
115 holders · 22.52M shares · 24 new positions · 67 increased · 31 reduced · 22 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Long Focus Capital Management, LLC | 3.59M | 6.61% | +301.6K | May 15, 2026 |
| BlackRock, Inc. | 2.83M | 5.20% | +158.0K | May 13, 2026 |
| Pathstone Holdings, LLC | 2.40M | 4.41% | +1.68M | May 11, 2026 |
| Americana Partners, LLC | 1.68M | 3.09% | +300.0K | May 12, 2026 |
| Vanguard Capital Management LLC | 1.45M | 2.67% | +1.45Mnew | May 15, 2026 |
| B Group, Inc. | 970.0K | 1.78% | +50.0K | May 15, 2026 |
| Geode Capital Management, LLC | 915.4K | 1.68% | +34.5K | May 15, 2026 |
| State Street Corp | 835.0K | 1.53% | +97.7K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Staffan Encrantzincl. Allegro Investment Fund, L.P., Allegro Investment Inc. | 13.10% | 6.73M | 13D | Mar 13, 2025 ↗ |
| Long Focus Capital Management, LLC | 6.00% | 3.13M | 13G | May 15, 2025 ↗ |
| BlackRock, Inc. | 5.01% | 2.65M | 13G | Jan 21, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Staffan Encrantz | director, 10 percent owner: | 6.52M | 11.99% | Jun 11, 2026 |
| Paul Badawi | director, 10 percent owner, officer: President and CEO | 6.12M | 11.25% | Jul 6, 2026 |
| David Badawi | director, officer: Chief Technology Officer | 1.98M | 3.64% | Jul 6, 2026 |
| Matthew Link | officer: Chief Commercial Officer | 832.3K | 1.53% | Jul 7, 2025 |
| Alison Bauerlein | officer: Chief Operating Officer | 664.7K | 1.22% | Jul 6, 2026 |
| Jeremy B. Hayden | officer: Chief Legal Officer | 357.0K | 0.66% | Jul 6, 2026 |
| Brenton Taylor | officer: EVP, Operations & R&D | 265.0K | 0.49% | Jul 6, 2026 |
| James Rodberg | officer: Chief Financial Officer | 224.0K | 0.41% | Jul 6, 2026 |
| Donald Zurbay | director | 193.6K | 0.36% | Jun 5, 2026 |
| Kashif Rashid | officer: Chief Legal Officer | 181.8K | 0.33% | Aug 18, 2026 |
2 ten-percent owners hold 7.78M shares by Form 4, outside the officers-and-directors figure above · 4 people have not refiled in the last 18 months (673.3K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 1, 2026 | Paul Badawidirector, 10 percent owner, officer: President and CEO | Sale | 28,684 | $5.42 | 6,122,472 |
| Jul 2, 2026 | Alison Bauerleinofficer: Chief Operating Officer | Sale | 24,184 | $5.36 | 664,709 |
| Jul 1, 2026 | Brenton Taylorofficer: EVP, Operations & R&D | Sale | 2,829 | $5.42 | 264,978 |
| Jul 6, 2026 | David Badawidirector, officer: Chief Technology Officer | Sale | 7,418 | $5.51 | 1,982,872 |
| Jul 2, 2026 | James Rodbergofficer: Chief Financial Officer | Sale | 6,902 | $5.36 | 224,037 |
| Jul 6, 2026 | Jeremy B. Haydenofficer: Chief Legal Officer | Sale | 12,733 | $5.51 | 357,037 |
| Jun 10, 2026 | Staffan Encrantzdirector, 10 percent owner: | Purchase | 14,100 | $4.88 | 1,434,283 |
| May 18, 2026 | Alison Bauerleinofficer: Chief Operating Officer | Sale | 12,728 | $5.12 | 688,893 |
| Apr 6, 2026 | Jeremy B. Haydenofficer: Chief Legal Officer | Sale | 13,761 | $3.55 | 369,770 |
| Apr 6, 2026 | James Rodbergofficer: Chief Financial Officer | Sale | 7,231 | $3.55 | 230,939 |
CongressHouse and Senate disclosures
Not reported.